Staging & Grading of oral cancer

OralPathMDS 827 views 28 slides May 26, 2021
Slide 1
Slide 1 of 28
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28

About This Presentation

Staging and Grading
Dr.Vasanthi


Slide Content

dr vasanthi v Department of Oral Pathology & Microbiology SRM Dental College, Ramapuram , Chennai, India Staging & grading of oral cancer

Sixth most common cancer in the world High frequency in Central and South East Asian countries 94% of all oral malignancies are squamous cell carcinoma Most common in India- 50-70% of total cancer morbidity 75% due to tobacco chewing or smoking

STAGING: Staging is based on clinical, radiological, and surgical criteria such as tumor size, involvement of regional lymph nodes and presence of metastases GRADING: Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type

TNM Staging STNMP staging STAGING SYSTEMS

TUMOR - NODE - METASTASIS STAGING (TNM) PARAMETERS Size of the lesion Nodal involvement Spread of the tumor Pierre Denoix 1940 Universal – UICC & AJCC-TNM classification cTNM & pTNM Expected to predict Clinical course of the tumor Prognosis Treatment plan Evaluation of response to treatment

www.clinicalgate.com

S-Site of primary tumor T- Size of tumor N-Nodal involvement M-Metastasis P-Pathology of lesion STNMP STAGING

Broder’s system (1920) WHO system (1972) Jakobsson’s system (1973) Anneroth’s system (1987) Bryne’s IFG system (1989) Histologic risk model (2005) BD model (2014) GRADING SYSTEMS

BRODER’S SYSTEM (1920) Grade I - 75% differentiated cells- Well differentiated Grade II - 50 – 75% differentiated cells- Moderately differentiated Grade III - 50 – 25% differentiated cells- Poorly differentiated Grade IV -25% differentiated cells-Undifferentiated Drawbacks Lack of correlation between grading and prognosis

WHO SYSTEM (1972) Grade I -Well differentiated Grade II -Moderately differentiated Grade III -Poorly differentiated

JAKOBSSON’S SYSTEM (1973) Histological grading of tumor – host r/s Mode of invasion Stage of invasion Vascular invasion Degree of lymphoplasmacytic infiltration Histologic grading of tumor cell Structure Tendency towards keratinization Nuclear aberrations No. of mitosis

JAKOBSSON SYSTEM

ANNEROTH’S SYSTEM (1987) Modified Jakobsson’s grading system Standard method – more specific result predicts prognosis guides for treatment plan

ANNEROTH’S SYSTEM Malignancy grading: Grade I: 6-12 Grade II: 13-18 Grade III : 19-24

BRYNE’S SYSTEM (1989) Malignancy grading of deep invasive margins at invasive tumor front (ITF) ITF- correlates with tumor aggressiveness, aberrant expression of cadherins , integrins High prognostic significance Drawbacks – Inter examiner variability Most cells are immature at invasive front

BRYNE’S SYSTEM (1989) Malignancy grading: Grade I - 4-8 Grade II - 9-12 Grade III - 13-16

HISTOLOGIC RISK MODEL (2005) Proposed by Brandwein – Gesler Evaluation of surgical specimen - 3 parameters WPOI – Worst Pattern of Invasion LHR - Lymphocyte Host Response PNI - Perineural invasion Drawbacks Evaluation after surgical resection- alter treatment plan Lymphatic and blood vessel invasion – not considered

HISTOLOGIC RISK MODEL (2005)

WPOI – Worst Pattern of Invasion

LHR-Lymphocyte Host Response

PNI - Perineural invasion

BD Model Proposed by Almangush B- Tumor budding D-Depth of invasion Tumor thickness Represents cellular discohesion and active invasion Low risk – Budding <5 , Depth <4 mm High risk – Budding > 5 , Depth > 4 mm

BD Model

BD Model – Tumor Budding

PROGNOSTIC EVALUATION Tumor related factors Growth pattern Micrometastasis Extracapsular spread Host/patient related factors Age, sex, habits Immune competence Co-morbidity Likely outcome of the disease 5 year survival rate Patients with lymph node involvement 20-36% after surgery Patients without lymph node involvement 63-86%

Staging is important in assessing prognosis, planning treatment and advising patients accordingly. The histopathological grading systems are useful in the prognostication of cancer, distinguishing low from high risk and proper treatment planning . CONCLUSION

REFERENCES The Prognostic Value Of Histopathological Grading Systems In Oral Squamous Cell Carcinomas, Sawazaki-Calone et al, Oral Diseases 2015 Comparative Study Of Various Grading Systems In Oral Squamous Cell Carcinoma And Their Value In Predicting Lymph Node Metastasis, Saleha Jamadar , Tv Narayan , Balasundari Shreedhar1, Leeky Mohanty , Sadhana Shenoy , Indian Journal Of Dental Research, 25(3), 2014 Depth Of Invasion, Tumor Budding, And Worst Pattern Of Invasion: Prognostic Indicators In Early-Stage Oral Tongue Cancer, Alhadi Almangush , Head & Neck—June 2014 Clinicopathological Prognostic Factors Of Oral Tongue Squamous Cell Carcinoma: A Retrospective Study Of 202 Cases, Rodrigues Et Al, Int. J. Oral Maxillofac . Surg. 2014. A Study On Histological Grading Of Oral Squamous Cell Carcinoma And Its Corelationship With Regional Metastasis, M Akhter , S Hossain , Quazi B Rahman , And Motiur R Molla Mayaug ; J Oral Maxillofac Pathol . 2011   Lymphocytic Host Response To Oral Squamous Cell Carcinoma: An Adaptive T-Cell Response At The Tumor Interface, Sara Maleki , Head And Neck Pathol 2011. Oral cancer structured reporting protocol, rcpath.com, 2011 Correlation Between TNM Classification And Malignancy Histological Feature Of Oral Squamous Cell Carcinoma, Antonio De L. L. Costa1, Raimundo F. De Araújo Júnior2, Carlos C. F. Ramos, Rev Bras Otorrinolaringol V.71, N.2, 181-7, Mar./Apr. 2005 Future Of The TNM Classification And Staging System In Head And Neck Cancer, Robert P. Takes Et Al, Robert P. Takes.